Illumina has revealed that it has acquired Edico Genome, with the intention of building on the solid foundation of DRAGEN, to deliver a more streamlines sample for customers.
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.
Medigene has agreed to expand its nearly two-year-old strategic alliance with Bluebird bio, focusing on the research and development of T-cell receptor-modified T-cell immunotherapies (TCR-T) for the treatment of cancer.
A controversial study has found that placing RNA from one sea slug into another appeared to transfer a simple version of a memory.
Researchers have slowed the growth of pancreatic cancer by harnessing CRISPR genome editing to remove key molecules implicated in its spread.
Researchers have uncovered a number of proteins that could play a critical role propagating signals within cells that can lead to uncontrolled cell growth—one of the hallmarks of cancer.
Tests to detect mutations in multiple genes are replacing BRCA-only analyses in women with breast cancer, according to a new study.
Researchers have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease. This is the first time researchers have successfully applied CRISPR technology to a type of inherited disease known as a dominant disorder.
Participants covering all aspects of science met at this year’s Genome-Project-write, to discuss how they were going to construct an entire genome from scratch.
A new method to screen for potential cancer drugs makes use of tiny, three-dimensional ball-like aggregates of cells called spheroids.
Researchers have developed a personalised risk assessment tool that can potentially predict the survival rate and treatment outcomes of early-stage lung cancer patients.
A U.S. start-up has entered the race to commercialise CRISPR. By using “base editing,” the company hope to treat some of the most devastating genetic disorders.
Researchers have developed a new platform that makes CRISPR less like a cutting tool and more like a word processor with a search-and-replace function.
For those planning to become parents, advances in sequencing technologies could make preconception carrier screening more useful by looking at a much broader set of genes.
Scientists have located sections of DNA that appear to play a role in controlling whether an individual’s skin burns or tans, which has laid the groundwork for genetic tests that could predict people’s responses to sunlight.